2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide

Catalog No. :
ACTYMZ631
CAS No. :
50508-89-9
Molecular Formula :
C15H13Cl2NO2S
Molecular Weight :
342.25

IUPAC Name:2-chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide

2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$90.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide
IUPAC Name2-chloro-N-(3-(2-chlorobenzoyl)-5-ethylthiophen-2-yl)acetamide
MDL No.MFCD18969310
Molecular FormulaC15H13Cl2NO2S
Molecular Weight342.25
SMILESO=C(NC1=C(C(C2=CC=CC=C2Cl)=O)C=C(CC)S1)CCl
InChI KeyRWDKLJQZPVCCTO-UHFFFAOYSA-N
Synonym2-(Chloroacetylamino)-3-(o-chlorobenzoyl)-5-ethylthiophene;2-(2-ChloroacetaMido)-3-(o-chlorobenzoyl)-5-ethylthiophene;[2-(2-chloro-acetylamino)-5-ethyl-thiophen-3-yl]-(2-chloro-phenyl)-methanone;Acetamide, 2-chloro-N-[3-(2-chlorobenzoyl)-5-ethyl-2-thienyl]-
CAS No.50508-89-9
PubChem CID12562369

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTYMZ631 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHKPW713 route compound structure diagram
    ACHKPW71350508-60-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTYMZ631 route product structure diagram
    ACTYMZ63150508-89-9 In Stock
Inquiry

2. ACTYMZ631 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTYMZ631 route product structure diagram
    ACTYMZ63150508-89-9 In Stock
Inquiry

Comments (0)